Entero Healthcare Solutions Limited — Board Meeting, 08-08-2025: Outcome of Board Meeting

Entero Healthcare's board approved the consolidated financial results for the quarter ended June 30, 2025. Revenue from operations reached ₹1403.82 Cr, with profit attributable to owners at ₹27.80 Cr. EPS stood at ₹6.39. The company extended the deadline for acquiring shares in Well Wisher Pharma, Khera Medisolutions, AV Medisolutions, and Anand Medical Distributors to November 30, 2025. Additionally, Entero acquired a 70% stake in Ramson Medical Distributors and increased its stake in Peerless Biotech to 76%. Post-quarter, a 70% stake in Sai RK Pharma was also acquired.